Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Researchers provide new data and prospects for links between gut microbiota and depression

An international group of researchers headed by André Carvalho has published in Psychotherapy and Psychosomatic a paper that provides new data and prospects for the links between the intestinal flora and several disorders, notably depression.

16 Feb 2017

Simple oral vitamin D spray could help extend lifespan

A simple oral vitamin D spray offering guaranteed faster absorption of vitamin D than tablets, could help lengthen your lifespan.

From BetterYou Ltd 16 Feb 2017

Researchers uncover reasons for differences between immune cells in males and females

Michigan State University researchers are the first to uncover reasons why a specific type of immune cell acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.

8 Feb 2017

Diet and antibiotic use can change gut microbiota contributing to IBS symptoms

A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS).

27 Jan 2017

Impact of IBS on patients

The report reveals a quite alarming situation about the economic impact of IBS on healthcare system, society and patients themselves. In particular, it disclosed that there are a lot of hidden costs related to the utilization of healthcare resources by means of patients, frequently not recognized as IBS...

16 Jan 2017

Women with IBS experience worse quality of life than men, new research shows

Double work and a high embarrassment factor can lead to the quality of life being affected more among women than men by irritable bowel syndrome (IBS), a very common gastrointestinal disease.

9 Jan 2017

Georgia Tech researchers find new way to improve treatment for inflammatory diseases

Is a treatment only making things better or maybe also making some things a little worse? That can be a nagging question in some medical decisions, where side effects are possible.

6 Jan 2017

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.

3 Jan 2017

Pasteurised intestinal bacterium could stop progression of obesity and diabetes in mice

The intestinal bacterium Akkermansia proves to offer enduring benefits for the intestines of overweight mice and diabetic animals.

30 Nov 2016

New study shows link between defective sucrase-isomaltase gene variants and IBS

Irritable bowel syndrome (IBS) affects a large portion of the general population. New research coordinated by Karolinska Institutet now shows a link between defective sucrase-isomaltase gene variants and IBS.

21 Nov 2016

FDA approves new assay for diagnosis of IBD

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).

16 Nov 2016

Identifying foods that trigger IBS: an interview with Dr Bill Chey

IBS is a common medical condition which is diagnosed in the presence of characteristic gastrointestinal symptoms including recurring bouts of abdominal pain and diarrhea and/or constipation. IBS patients also commonly report bloating and abdominal distension or swelling.

15 Nov 2016

Primary headache patients diagnosed with more comorbidities have high healthcare costs, research shows

Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000.

24 Oct 2016

New report underscores personal and economic impact of IBS

A multi-disciplinary expert group calls for greater attention to be paid to Irritable Bowel Syndrome (IBS) to bring it out of the shadows. The IBS Global Impact Report is launched at United European Gastroenterology Week and examines published studies on the direct and indirect costs of IBS.

19 Oct 2016

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.

12 Oct 2016

Alternative therapies appear to be effective in ameliorating IBS symptoms

A new review looks at the evidence behind the effectiveness of complementary or alternative therapies-including probiotics, prebiotics, synbiotics, fiber, and herbal medicinal products-for the treatment of bowel disorders such as irritable bowel syndrome (IBS), functional constipation, and ulcerative colitis.

3 Oct 2016

Harvard symposium highlights health impact of gut microbiota and probiotics throughout lifespan

Danone Nutricia Research, one of the key sponsors of the September 15th and 16th Harvard Medical School Division of Nutrition symposium on gut microbiota, probiotics and their impact throughout the lifespan, announces its continued support of research in the emerging field of the microbiome and its interactions with body functions.

30 Sep 2016

New partnership between BetterYou and University of Sheffield paves way for vitamin D research

A new collaboration between health pioneers BetterYou and scientists from the University of Sheffield, is paving the way for a three-year clinical trial looking at the effect of vitamin D supplementation on the quality of life of people with Irritable Bowel Syndrome (IBS).

From BetterYou Ltd 21 Sep 2016

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances.

15 Sep 2016

Study demonstrates significant reduction in severity of exercise-induced asthma following B-GOS consumption

Clasado Biosciences Limited, the producers and suppliers of Bimuno(R) (B-GOS), a unique patented trans-galactooligosaccharide complex, today announces the publication of results for the latest clinical study using B-GOS.

5 Aug 2016

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Researchers provide new data and prospects for links between gut microbiota and depression

Simple oral vitamin D spray could help extend lifespan

Researchers uncover reasons for differences between immune cells in males and females

Diet and antibiotic use can change gut microbiota contributing to IBS symptoms

Impact of IBS on patients

Women with IBS experience worse quality of life than men, new research shows

Georgia Tech researchers find new way to improve treatment for inflammatory diseases

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Pasteurised intestinal bacterium could stop progression of obesity and diabetes in mice

New study shows link between defective sucrase-isomaltase gene variants and IBS

FDA approves new assay for diagnosis of IBD

Identifying foods that trigger IBS: an interview with Dr Bill Chey

Primary headache patients diagnosed with more comorbidities have high healthcare costs, research shows

New report underscores personal and economic impact of IBS

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Alternative therapies appear to be effective in ameliorating IBS symptoms

Harvard symposium highlights health impact of gut microbiota and probiotics throughout lifespan

New partnership between BetterYou and University of Sheffield paves way for vitamin D research

Food intolerance testing: an interview with Dr Gill Hart

Study demonstrates significant reduction in severity of exercise-induced asthma following B-GOS consumption

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in